Regulation of reactive oxygen species in stem cells and cancer stem cells

Chiharu I Kobayashi1, Toshio Suda

  • 1Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Insights

Stem cells use reactive oxygen species (ROS) for self-renewal and tissue repair. Understanding ROS regulation in normal and cancer stem cells is key for effective therapies.

Area of Science:

  • Stem cell biology
  • Redox biology
  • Cancer stem cell research

Background:

  • Stem cells self-renew and differentiate, maintaining tissue homeostasis.
  • Aerobic metabolism produces reactive oxygen species (ROS), which can damage cells.
  • While ROS damage is known, redox status also regulates stem cell function, including cell cycle control.

Purpose of the Study:

  • To review the mechanisms of redox regulation in normal stem cells, cancer cells, and cancer stem cells.
  • To highlight the importance of understanding ROS regulatory mechanisms for stem cell maintenance and cancer therapy.

Main Methods:

  • Literature review of redox regulation in stem cells.
  • Comparison of ROS levels and patterns in normal stem cells, cancer cells, and cancer stem cells.

Main Results:

  • Reactive oxygen species (ROS) play a dual role in stem cells: damaging at high levels but regulatory at specific concentrations.
  • Some cancer stem cells exhibit low ROS levels, similar to normal stem cells, contrasting with high ROS in typical cancer cells.
  • Redox status is crucial for cell cycle regulation and stem cell maintenance.

Conclusions:

  • Understanding the distinct redox profiles of normal stem cells, cancer cells, and cancer stem cells is essential.
  • Targeting specific ROS regulatory mechanisms may offer novel therapeutic strategies for cancer stem cells.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...